Seeking Alpha
 

Heska Corporation (HSKA)

- NASDAQ
  • Oct. 29, 2014, 3:09 PM
    • Heska (HSKA +4.2%) Q3 results: Revenues: $21.8M (+23.9%); Gross Profit: $8.3M (+12.2%); Operating Expense: $8M (+9.6%); Operating Income: $341K (+354.7%); Net Income: $513K (+112.9%); EPS: $0.08 (+100.0%); Quick Assets: $5.8M (-3.3%).
    • No guidance given.
    | Comment!
  • Oct. 29, 2014, 9:04 AM
    • Heska (NASDAQ:HSKA): Q3 EPS of $0.08 beats by $0.09.
    • Revenue of $21.81M (+23.9% Y/Y) beats by $2.33M.
    • Press Release
    | Comment!
  • Jul. 30, 2014, 10:11 AM
    • Heska Corp. (HSKA +11.1%) Q2 results: Revenues: $22.9M (+25.1%); Gross Profit: $9.1M (+82.0%); Operating Expenses: $8.2M (-4.7%); Operating Income: $917K (+125.0%); Net Income: $778K (+132.0%); EPS: $0.17 (+144.7%); Quick Assets: $6.3M (+5.0%).
    • No guidance given.
    | Comment!
  • Jul. 30, 2014, 9:16 AM
    • Heska (NASDAQ:HSKA): Q2 EPS of $0.17 beats by $0.20.
    • Revenue of $22.9M (+25.1% Y/Y) beats by $3.12M.
    • Shares +18% PM.
    • Press Release
    | Comment!
  • Mar. 27, 2014, 9:10 AM
    • Heska (HSKA): Q4 EPS of $0.20 beats by $0.16.
    • Revenue of $23.5M (+27.0% Y/Y) beats by $4.66M.
    • Press Release
    | Comment!
  • Aug. 7, 2013, 9:27 AM
    • Heska (HSKA): Q2 EPS of -$0.38 misses by $0.37.
    • Revenue of $18.3M misses by $1.55M. (PR)
    | Comment!
  • May. 15, 2013, 6:29 AM
    Heska (HSKA): Q1 EPS of -$0.07 misses by $0.19. Revenue of $19M misses by $1.95M. (PR)
    | Comment!
  • Feb. 25, 2013, 4:50 PM
    Heska (HSKA): Q4 EPS of $0.07 beats by $0.04. Revenue of $18.5M (+19% Y/Y) beats by $1M. Shares -5.1% AH. (PR)
    | Comment!
  • Nov. 13, 2012, 4:15 PM
    Heska (HSKA): Q3 EPS of -$0.01 misses by $0.09. Revenue of $16.9M (-4% Y/Y) misses by $3M. (PR)
    | Comment!
Visit Seeking Alpha's
HSKA vs. ETF Alternatives
Company Description
Heska Corp is engaged in developing, manufacturing, marketing, selling and supporting veterinary products. The Company's core focus is on the canine and feline companion animal health markets.
Sector: Healthcare
Industry: Biotechnology
Country: United States